Archimedes Tech SPAC Partners II Co. Files Third Amendment To Registration Statement On Form S-4 With The SEC

Archimedes Tech SPAC Partners II Obtains Shareholder Approval Of Proposed Business Combination With Forge Nano; Combined Company To Trade As "NANO" And "NANOW" On Nasdaq

rchimedes Tech SPAC Partners II Co. (NASDAQ:ATII) ("Archimedes II" or "ATII"), a publicly traded special purpose acquisition company, today announced that at the Extraordinary General Meeting (the

Archimedes Tech SPAC Partners II Announces Its SEC's Registration Statement On Form S-4 Declared Effective For Its Proposed Business Combination With Forge Nano

Archimedes Tech SPAC Partners II Co. (Nasdaq: ATII) ("Archimedes II" or "ATII"), a publicly traded special purpose acquisition company, today announced that its registration statement on Form S-4 (the

Archimedes Tech SPAC Partners II Merger Partner Forge Nano Signs Joint Development Agreement With Nanexa To Develop Scalable Pharmaceutical Manufacturing Capabilities For The PharmaShell Drug Delivery Platform

Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale

Forge Nano, Merging With Archimedes Tech SPAC Partners II, Announces Expanded Agreement With Voltaiq To Deploy Battery Intelligence And AI Analytics Platform Across U.S. Battery Operations; Terms Not Disclosed